Biotech outsourcing strategies cmc--biologics stream. June 17, 2010, Copenhagen, Denmark.
Now in its third year, the Biotech Outsourcing Strategies (BOS) meeting organized by Bio2Business took place at the Søhuset Conference Centre in Hørsholm, Copenhagen. The focus of this year's event was the demanding and challenging area of chemistry, manufacturing and controls (CMC), and the meeting provided ample opportunity for lively discussion of the key issues surrounding this area. New for the 2010 conference, a biologics-focused lecture stream ran in parallel to the established small molecule stream. Both streams boasted a distinguished panel of keynote speakers who discussed all aspects of CMC from early stage scale-up through late stage clinical development. In addition to the keynote speakers, selected contract research organizations (CROs) gave short presentations on the solutions that they could provide to some of the challenges facing CMC. The meeting attracted more than 150 delegates from leading drug development companies and CRO service providers, and greatly facilitated the forging of new working relationships through pre-arranged one-to-one meetings. Moreover, exhibitions from event sponsors and considerable scheduled networking time over lunch and evening reception further enhanced the highly productive and interactive nature of the meeting.
Hamer
Kate
K
School of Chemistry, University of Nottingham, University Park, Nottingham, UK. pcxkh2@nottingham.ac.uk
D000911:Antibodies, Monoclonal / Q000096:biosynthesis* / Q000627:therapeutic use; D004345:Drug Industry / Q000379:methods / Q000639:trends; D006801:Humans; D020416:Outsourced Services; D013678:Technology, Pharmaceutical / Q000191:economics / Q000379:methods* / Q000639:trends
D000911:Antibodies, Monoclonal